{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:54:58Z","timestamp":1792036498566,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":106,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02232","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T06:46:31Z","timestamp":1744958791000},"page":"e02232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rezafungin for suppressive therapy of Candida auris in a patient with a left ventricular assist device (LVAD)"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5585-1675","authenticated-orcid":false,"given":"Matthew A.","family":"Stack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Hasbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun O.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Babic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.idcr.2025.e02232_bib1","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02232_bib2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02232_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/502581","article-title":"Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance","volume":"26","author":"Morgan","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02232_bib4","article-title":"Treatment of invasive candidiasis: a narrative review","volume":"4","author":"Ben-Ami","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02232_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02232_bib6","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02232_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01627-16","article-title":"Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults","volume":"61","author":"Sandison","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"10370","key":"10.1016\/j.idcr.2025.e02232_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02232_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae286","article-title":"Fungal foe and mechanical hearts: a retrospective case series on candida auris bloodstream infection with left ventricular assist Devices","volume":"11","author":"Kerai","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02232_bib10","article-title":"Epidemiological trends of candidemia and the impact of adherence to the candidemia guideline: six-year single-center experience","volume":"7","author":"Kim","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"_1","key":"10.1016\/j.idcr.2025.e02232_bib11","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02232_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02232_bib13","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/jac\/dkac206","article-title":"Successful expanded access use of rezafungin, a novel echinocandin, to eradicate refractory invasive candidiasis in a liver transplant recipient","volume":"77","author":"Pechacek","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02232_bib14","article-title":"Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report","volume":"6","author":"Mori","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02232_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12050903","article-title":"Salvage therapy with Rezafungin for Candida parapsilosis spondylodiscitis: a case report from expanded access program","volume":"12","author":"Viceconte","year":"2024","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.idcr.2025.e02232_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apm.13336","article-title":"Azole resistance in Candida auris: mechanisms and combinatorial therapy","volume":"131","author":"Jangir","year":"2023","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02232_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad703","article-title":"Healthcare resource utilization and discharge readiness in adult hospitalized patients with candidemia or invasive candidiasis who received an echinocandin: an analysis of United States hospitals","volume":"11","author":"Lodise","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02232_bib18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.athoracsur.2015.03.010","article-title":"Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis","volume":"100","author":"Akhter","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02232_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchf.2016.09.008","article-title":"Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure","volume":"5","author":"Baras Shreibati","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02232_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13696998.2023.2292912","article-title":"Clinical and economic impact of ventricular assist device infections: a real-world claims analysis","volume":"27","author":"Peleg","year":"2024","journal-title":"J Med Econ"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02232_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00916-23","article-title":"Population pharmacokinetic modeling and target attainment analyses of rezafungin for the treatment of candidemia and invasive candidiasis","volume":"67","author":"Roepcke","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02232_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02614-17","article-title":"Overcoming the resistance hurdle: pharmacokinetic-pharmacodynamic target attainment analyses for rezafungin (CD101) against Candida albicans and Candida glabrata","volume":"62","author":"Bader","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02232_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jac\/dkae415","article-title":"The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics","volume":"80","author":"Andes","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02232_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MAT.0000000000000886","article-title":"Pharmacokinetics of sildenafil in patients with a left ventricular assist device: a word of caution","volume":"65","author":"Sabato","year":"2019","journal-title":"ASAIO J"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02232_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0897190019894424","article-title":"Phenytoin serum concentrations in patients with left ventricular support devices: a case series","volume":"34","author":"Wiebe","year":"2021","journal-title":"J Pharm Pr"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:24:06Z","timestamp":1749554646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"alternative-id":["S2214250925000873"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02232","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rezafungin for suppressive therapy of Candida auris in a patient with a left ventricular assist device (LVAD)","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02232"}}